267 related articles for article (PubMed ID: 27903811)
21. Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.
Fotiadis P; van Rooden S; van der Grond J; Schultz A; Martinez-Ramirez S; Auriel E; Reijmer Y; van Opstal AM; Ayres A; Schwab KM; ; Hedden T; Rosand J; Viswanathan A; Wermer M; Terwindt G; Sperling RA; Polimeni JR; Johnson KA; van Buchem MA; Greenberg SM; Gurol ME
Lancet Neurol; 2016 Jul; 15(8):811-819. PubMed ID: 27180034
[TBL] [Abstract][Full Text] [Related]
22. Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
Noguchi-Shinohara M; Komatsu J; Samuraki M; Matsunari I; Ikeda T; Sakai K; Hamaguchi T; Ono K; Nakamura H; Yamada M
J Alzheimers Dis; 2017; 55(3):905-913. PubMed ID: 27802236
[TBL] [Abstract][Full Text] [Related]
23. Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers.
Schultz AP; Kloet RW; Sohrabi HR; van der Weerd L; van Rooden S; Wermer MJH; Moursel LG; Yaqub M; van Berckel BNM; Chatterjee P; Gardener SL; Taddei K; Fagan AM; Benzinger TL; Morris JC; Sperling R; Johnson K; Bateman RJ; ; Gurol ME; van Buchem MA; Martins R; Chhatwal JP; Greenberg SM
Ann Neurol; 2019 Oct; 86(4):616-625. PubMed ID: 31361916
[TBL] [Abstract][Full Text] [Related]
24. Cerebral vascular accumulation of Dutch-type Abeta42, but not wild-type Abeta42, in hereditary cerebral hemorrhage with amyloidosis, Dutch type.
Nishitsuji K; Tomiyama T; Ishibashi K; Kametani F; Ozawa K; Okada R; Maat-Schieman ML; Roos RA; Iwai K; Mori H
J Neurosci Res; 2007 Oct; 85(13):2917-23. PubMed ID: 17628026
[TBL] [Abstract][Full Text] [Related]
25. Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App
Andersson E; Schultz N; Saito T; Saido TC; Blennow K; Gouras GK; Zetterberg H; Hansson O
Alzheimers Res Ther; 2023 Mar; 15(1):64. PubMed ID: 36964585
[TBL] [Abstract][Full Text] [Related]
26. Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light.
Schindler SE; Karikari TK; Ashton NJ; Henson RL; Yarasheski KE; West T; Meyer MR; Kirmess KM; Li Y; Saef B; Moulder KL; Bradford D; Fagan AM; Gordon BA; Benzinger TLS; Balls-Berry J; Bateman RJ; Xiong C; Zetterberg H; Blennow K; Morris JC
Neurology; 2022 Jul; 99(3):e245-e257. PubMed ID: 35450967
[TBL] [Abstract][Full Text] [Related]
27. CSF neurofilament light concentration is increased in presymptomatic
Rostgaard N; Roos P; Portelius E; Blennow K; Zetterberg H; Simonsen AH; Nielsen JE
Neurology; 2018 Jan; 90(2):e157-e163. PubMed ID: 29237796
[TBL] [Abstract][Full Text] [Related]
28. Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment.
Janelidze S; Pannee J; Mikulskis A; Chiao P; Zetterberg H; Blennow K; Hansson O
JAMA Neurol; 2017 Dec; 74(12):1492-1501. PubMed ID: 29114726
[TBL] [Abstract][Full Text] [Related]
29. Reduced Levels of Cerebrospinal Fluid/Plasma Aβ40 as an Early Biomarker for Cerebral Amyloid Angiopathy in RTg-DI Rats.
Zhu X; Xu F; Hoos MD; Lee H; Benveniste H; Nostrand WEV
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906317
[TBL] [Abstract][Full Text] [Related]
30. Enhanced Abeta40 deposition was associated with increased Abeta42-43 in cerebral vasculature with Dutch-type hereditary cerebral hemorrhage with amyloidosis (HCHWA-D).
Ozawa K; Tomiyama T; Maat-Schieman ML; Roos RA; Mori H
Ann N Y Acad Sci; 2002 Nov; 977():149-54. PubMed ID: 12480745
[TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy.
Verbeek MM; Kremer BP; Rikkert MO; Van Domburg PH; Skehan ME; Greenberg SM
Ann Neurol; 2009 Aug; 66(2):245-9. PubMed ID: 19743453
[TBL] [Abstract][Full Text] [Related]
32. Glial reactions and the clearance of amyloid beta protein in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type.
Maat-Schieman ML; Yamaguchi H; Hegeman-Kleinn IM; Welling-Graafland C; Natté R; Roos RA; van Duinen SG
Acta Neuropathol; 2004 May; 107(5):389-98. PubMed ID: 15014955
[TBL] [Abstract][Full Text] [Related]
33. Hereditary cerebral hemorrhage with amyloidosis Dutch type (AbetaPP 693): decreased plasma amyloid-beta 42 concentration.
Bornebroek M; De Jonghe C; Haan J; Kumar-Singh S; Younkin S; Roos R; Van Broeckhoven C
Neurobiol Dis; 2003 Dec; 14(3):619-23. PubMed ID: 14678776
[TBL] [Abstract][Full Text] [Related]
34. Age-related plaque morphology and C-terminal heterogeneity of amyloid beta in Dutch-type hereditary cerebral hemorrhage with amyloidosis.
Maat-Schieman ML; Yamaguchi H; van Duinen SG; Natté R; Roos RA
Acta Neuropathol; 2000 Apr; 99(4):409-19. PubMed ID: 10787040
[TBL] [Abstract][Full Text] [Related]
35. Presymptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy-Related Blood Metabolite Alterations.
Chatterjee P; Fagan AM; Xiong C; McKay M; Bhatnagar A; Wu Y; Singh AK; Taddei K; Martins I; Gardener SL; Molloy MP; Multhaup G; Masters CL; Schofield PR; Benzinger TLS; Morris JC; Bateman RJ; Greenberg SM; Wermer MJH; van Buchem MA; Sohrabi HR; Martins RN;
J Alzheimers Dis; 2021; 79(2):895-903. PubMed ID: 33361604
[TBL] [Abstract][Full Text] [Related]
36. Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice.
Sauvée M; DidierLaurent G; Latarche C; Escanyé MC; Olivier JL; Malaplate-Armand C
J Alzheimers Dis; 2014; 41(2):377-86. PubMed ID: 24614902
[TBL] [Abstract][Full Text] [Related]
37. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.
Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM
JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585
[TBL] [Abstract][Full Text] [Related]
38. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
39. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
[TBL] [Abstract][Full Text] [Related]
40. Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.
McCarter SJ; Lesnick TG; Lowe VJ; Rabinstein AA; Przybelski SA; Algeciras-Schimnich A; Ramanan VK; Jack CR; Petersen RC; Knopman DS; Boeve BF; Kantarci K; Vemuri P; Mielke MM; Graff-Radford J
J Alzheimers Dis; 2022; 87(4):1537-1547. PubMed ID: 35527558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
